Laboratory Test Preparation

| Test | : | Japanese Encephalitis |
| Other Test Request Name | : | Not applicable |
| Test Composition | : | Not applicable |
| Intended Use | : | Japanese encephalitis virus (JEV) is the most important cause of viral encephalitis in Asia. It is a mosquito-borne flavivirus, and belongs to the same genus as dengue, yellow fever and West Nile viruses. |
| Methodology | : | Capture ELISA |
| Laboratory Section | : | Special Test |
| Special Instructions/Patient Preparations | : | No patient preparation necessary. |
| Collection/Sample Container | : | Red Tube only (No Gel Separator) |
| Specimen and Volume Requirement Note:Follow tube manufacturer recommendation. | : | 3 mL Serum |
| Alternative Specimen and Volume Requirement | : | 2 mL CSF |
| Specimen Stability | ||
| • Room Temperature (15-25°C) | : | 14 Days |
| • Refrigerated Temperature (2-8°C) | : | 14 Days |
| • Freezer Temperature (-20°C) | : | 30 Days |
| Transport Temperature | : | Transport specimen at 2 – 8 °C (with cold packs) |
| Rejection Criteria | : | • Hemolyzed specimen |
| Running Day | : | Wednesday 8:00 AM |
| Cut Off Time | : | Tuesday 4:00 PM |
| TAT/Releasing of Results | : | After 3 days (excluding Saturdays, Sundays and Holidays) |
| Reference Interval/Result Interpretation | : | Available upon request |
| Limitations/Interferences | : | None specified. |
| Frequently Asked Questions (FAQs) | : | Not applicable |
| Related Words/Test | : | Japanese B encephalitis, mosquito-borne |
| Test | : | JC-Polyomavirus (PCR) |
| Other Test Request Name | : | • JCV-PCR • John Cunningham Virus |
| Test Composition | : | Not applicable |
| Intended Use | : | JC virus is the polyomavirus which causes progressive multifocal leukoencephalopathy, a fatal neurological infection which affects patients who are immunodeficient for long periods. In practice, the virus cannot be isolated but a reliable diagnosis can be based on the detection of viral DNA by PCR assay in a CSF specimen or brain biopsy material. No practical serological tests have been developed. |
| Methodology | : | Polymerase Chain Reaction (PCR) |
| Laboratory Section | : | Special Test |
| Special Instructions/Patient Preparations | : | Blood sample will be drawn every Wednesday-Thursday from 8am-6pm. |
| Collection/Sample Container | : | EDTA or Violet Tube |
| Specimen and Volume Requirement Note:Follow tube manufacturer recommendation. | : | 4 mL whole blood |
| Alternative Specimen and Volume Requirement | : | • 2 ml CSF in Sterile Container |
| Specimen Stability | ||
| • Room Temperature (15-25°C) | : | 48 Hours |
| • Refrigerated Temperature (2-8°C) | : | 7 Days |
| • Freezer Temperature (-20°C) | : | Not Applicable |
| Transport Temperature | : | Transport specimen at 2 – 8 °C (with cold packs) |
| Rejection Criteria | : | • Hemolyzed specimen |
| Running Day | : | Batch Running |
| Cut Off Time | : | Friday 4:00 PM |
| TAT/Releasing of Results | : | 3 weeks after cut-off (excluding Saturdays, Sundays and Holidays) |
| Reference Interval/Result Interpretation | : | Not Applicable |
| Limitations/Interferences | : | None specified. |
| Frequently Asked Questions (FAQs) | : | Not applicable |
| Related Words/Test | : | John Cunningham virus, progressive multifocal leukoencephalopathy |
| Test | : | Kappa/Lambda Chains |
| Other Test Request Name | : |
|
| Test Composition | : | Kappa Lambda Kappa/Lambda Ratio |
| Intended Use | : | •To help detect , diagnose and monitor plasma cell disorders (dyscrasias), including multiple myeloma and primary amyloidosis. |
| Methodology | : | Nephelometry |
| Laboratory Section | : | Special Test |
| Special Instructions/Patient Preparations | : | No patient preparation necessary. |
| Collection/Sample Container | : | Red or Gold Tube |
| Specimen and Volume Requirement Note:Follow tube manufacturer recommendation. | : | 3 mL Serum |
| Alternative Specimen and Volume Requirement | : | Not Applicable |
| Specimen Stability | ||
| • Room Temperature (15-25°C) | : | 48 Hours |
| • Refrigerated Temperature (2-8°C) | : | 8 Days |
| • Freezer Temperature (-20°C) | : | 30 Days |
| Transport Temperature | : | Transport specimen at 2 – 8 °C (with cold packs) |
| Rejection Criteria | : | • Hemolyzed specimen |
| Running Day | : | Batch Running |
| Cut Off Time | : | Monday, 12:00 PM
|
| TAT/Releasing of Results | : | 2 weeks after cut-off (excluding Saturdays, Sundays and Holidays) |
| Reference Interval/Result Interpretation | : | Available upon request |
| Limitations/Interferences | : | None specified. |
| Frequently Asked Questions (FAQs) | : | Not applicable |
| Related Words/Test | : | Not Applicable |
| Test | : | Kappa/Lambda Chains |
| Other Test Request Name | : | Free Light Chain |
| Test Composition | : | Not Applicable |
| Intended Use | : | •To help detect , diagnose and monitor plasma cell disorders (dyscrasias), including multiple myeloma and primary amyloidosis. |
| Methodology | : | Electrochemiluminescence Immunoassay (ECLIA) |
| Laboratory Section | : | Special Test |
| Special Instructions/Patient Preparations | : | No patient preparation necessary |
| Collection/Sample Container | : | Red or Gold Tube |
| Specimen and Volume Requirement Note:Follow tube manufacturer recommendation. | : | 3 mL Serum |
| Alternative Specimen and Volume Requirement | : | Not Applicable |
| Specimen Stability | ||
| • Room Temperature (15-25°C) | : | 48 Hours |
| • Refrigerated Temperature (2-8°C) | : | 21 Days |
| • Freezer Temperature (-20°C) | : | Not applicable |
| Transport Temperature | : | Transport specimen at 2 – 8 °C (with cold packs) |
| Rejection Criteria | : |
|
| Running Day | : | Monday 7am |
| Cut Off Time | : | Friday 7am |
| TAT/Releasing of Results | : | 10 Working days after cut-off (excluding Saturdays, Sundays and Holidays) |
| Reference Interval/Result Interpretation | : | Not Applicable |
| Limitations/Interferences | : | Not Applicable |
| Frequently Asked Questions (FAQs) | : | Not Applicable |
| Related Words/Test | : | Not Applicable |
| Test | : | Katocatz/Kato thick |
| Other Test Request Name | : | • Kato Thick Smear • Kato technique |
| Test Composition | : | Not applicable |
| Intended Use | : | The Katokatz is most commonly used for detecting schistosome eggs but can also be used for the identification of other helminth eggs. |
| Methodology | : | Direct Microscopic Examination |
| Laboratory Section | : | Clinical Microscopy |
| Special Instructions/Patient Preparations | : | No patient preparation necessary. |
| Collection/Sample Container | : | Clean, leak-proof container |
| Specimen and Volume Requirement Note:Follow tube manufacturer recommendation. | : | Pea sized or size of 25 centavo coin stool |
| Alternative Specimen and Volume Requirement | : | Not applicable |
| Specimen Stability | ||
| • Room Temperature (15-25°C) | : | 2 Hours |
| • Refrigerated Temperature (2-8°C) | : | Not applicable |
| • Freezer Temperature (-20°C) | : | Not applicable |
| Transport Temperature | : | Transport specimens immediately to HPD Laboratory at room temperature (15-25°C) within 2 hours. NOTE: Do not delay transport of samples. |
| Rejection Criteria | : | • Quantity not sufficient (QNS); samples less than pea-sized stool • Contaminated stool (e.g. with urine or other body fluids) • Stool not delivered immediately in the laboratory within 2 hours. |
| Running Day | : | Daily |
| Cut Off Time | : | Monday to Saturday • 6:00 PM Sunday • 3:00 PM |
| TAT/Releasing of Results | : | ROUTINE • 3 hours after receipt of specimen/ arrival of messenger STAT • After 1½ hours from receipt of specimen/ arrival of messenger |
| Reference Interval/Result Interpretation | : | NO INTERTINAL PARASITE SEEN |
| Limitations/Interferences | : | Diarrheic or watery stool and /or stool contaminated with other fluids may affect test results.. |
| Frequently Asked Questions (FAQs) | : | Not applicable |
| Related Words/Test | : | Diarrhea |
| Test | : | Keppra |
| Other Test Request Name | : | Levetiracetam |
| Test Composition | : | Not applicable |
| Intended Use | : | Kepra or Levetiracetam is an anticonvulsant used as adjunct therapy to treat adult partial seizures. As multiple anticonvulsants are administered, it is important to monitor its level to: |
| Methodology | : | Liquid Chromatography Mass Spectrometry (LCMS) |
| Laboratory Section | : | Special Test |
| Special Instructions/Patient Preparations | : | • No patient preparation necessary.
|
| Collection/Sample Container | : | Red tube (DO NOT USE GOLD TUBE or any other type of tube with gel separator) |
| Specimen and Volume Requirement Note:Follow tube manufacturer recommendation. | : | 3 mL Serum |
| Alternative Specimen and Volume Requirement | : | Not Applicable |
| Specimen Stability | ||
| • Room Temperature (15-25°C) | : | 14 Days |
| • Refrigerated Temperature (2-8°C) | : | 28 Days |
| • Freezer Temperature (-20°C) | : | 60 Days |
| Transport Temperature | : | Transport specimen at 2 – 8 °C (with cold packs) |
| Rejection Criteria | : | • Hemolyzed specimen |
| Running Day | : | Batch Running |
| Cut Off Time | : | Friday 4:00 PM |
| TAT/Releasing of Results | : | 2 weeks after cut-off (excluding Saturdays, Sundays and Holidays) |
| Reference Interval/Result Interpretation | : | Available upon request |
| Limitations/Interferences | : | None specified. |
| Frequently Asked Questions (FAQs) | : | Not applicable |
| Related Words/Test | : | Used to treat epilepsy |
| Test | : | Ketone (Serum) |
| Other Test Request Name | : |
|
| Test Composition | : | Not applicable |
| Intended Use | : | Useful in the diagnosis and monitoring of therapy for diabetic ketoacidosis |
| Methodology | : | Nitroprusside |
| Laboratory Section | : | Special Test |
| Special Instructions/Patient Preparations | : | No patient preparation necessary. |
| Collection/Sample Container | : | Red or Gold Tube |
| Specimen and Volume Requirement Note:Follow tube manufacturer recommendation. | : | 3 mL Serum |
| Alternative Specimen and Volume Requirement | : | Not Applicable |
| Specimen Stability | ||
| • Room Temperature (15-25°C) | : | 14 Days |
| • Refrigerated Temperature (2-8°C) | : | 14 Days |
| • Freezer Temperature (-20°C) | : | Not applicable |
| Transport Temperature | : | Transport specimen at 2 – 8 °C (with cold packs) |
| Rejection Criteria | : |
|
| Running Day | : | Monday to Friday |
| Cut Off Time | : | Monday to Friday, 7:00 AM |
| TAT/Releasing of Results | : | After 3 days(excluding Saturdays, Sundays and Holidays) |
| Reference Interval/Result Interpretation | : | Available upon request |
| Limitations/Interferences | : | None specified. |
| Frequently Asked Questions (FAQs) | : | Not applicable |
| Related Words/Test | : | Not Applicable |
| Test | : | Kidney Stone Analysis By FTIR |
| Other Test Request Name | : | • Urinary Stone Analysis |
| Test Composition | : | Not applicable |
| Intended Use | : | Used to evaluate the composition of kidney stones to determine the cause of formation and subsequent treatment, if possible. |
| Methodology | : | Fourier Transform Infrared Spectroscopy (FTIR) |
| Laboratory Section | : | Clinical Microscopy |
| Special Instructions/Patient Preparations | : | Hospital Collections: as instructed by your physician |
| Collection/Sample Container | : | Specimen collection kit provided by HPD or any clean container |
| Specimen and Volume Requirement Note:Follow tube manufacturer recommendation. | : | 20 mg, or at least the size equivalent of 2-3 small grains of rice |
| Alternative Specimen and Volume Requirement | : | Not applicable |
| Specimen Stability | ||
| • Room Temperature (15-25°C) | : | 1 Year |
| • Refrigerated Temperature (2-8°C) | : | Unacceptable |
| • Freezer Temperature (-20°C) | : | Unacceptable |
| Transport Temperature | : | Transport specimen at 15 °C – 25 °C (Room Temperature) |
| Rejection Criteria | : | • Stones immersed in any other liquid other than water |
| Running Day | : | Daily except Sundays and Holidays samples received on Sundays will be processed the next day. |
| Cut Off Time | : | 1:00 PM samples received after cut off time will be processed the next day. |
| TAT/Releasing of Results | : | 1 day from receipt of specimen / messenger arrival |
| Reference Interval/Result Interpretation | : | Not applicable |
| Limitations/Interferences | : | Presence of water or moisture in sample will cause interference in the spectrum |
| Frequently Asked Questions (FAQs) | : | Q: How is the test being used? A: A kidney stone analysis is performed to determine the chemical composition of a stone when it is filtered out of the urine or removed from the urinary tract. A laboratory will typically document the physical characteristics of a stone – its size, shape, weight, color, and texture. One or more tests will then be performed to determine the stone's composition.
|
| Related Words/Test | : | Urolithiasis, Nephrolithiasis, Urinalysis, Uric Acid, Calcium, Phosphorus, Creatinine, Oxalate, Citrate, Cystine |
| Test | : | Kidneys / Renal Ultrasound |
| Other Test Request Name | : | - |
| Test Composition | : | Not Applicable |
| Intended Use | : | Ultrasound imaging or sonography is considered to be a non-invasive procedure and does not involve ionizing radiation which is usual in X-rays. An ultrasound scan is not only useful in assessing the structure of organs and different internal structures but can also show the movement of organs in real time. It may be used to assess the size and structures of the following:
|
| Methodology | : | Not Applicable |
| Laboratory Section | : | Not Applicable |
| Special Instructions/Patient Preparations | : | PREPARATION
|
| Collection/Sample Container | : | Not Applicable |
| Specimen and Volume Requirement Note:Follow tube manufacturer recommendation. | : | Not Applicable |
| Alternative Specimen and Volume Requirement | : | Not Applicable |
| Specimen Stability | ||
| • Room Temperature (15-25°C) | : | Not Applicable |
| • Refrigerated Temperature (2-8°C) | : | Not Applicable |
| • Freezer Temperature (-20°C) | : | Not Applicable |
| Transport Temperature | : | Not Applicable |
| Rejection Criteria | : | Not Applicable |
| Running Day | : | Not Applicable |
| Cut Off Time | : | Not Applicable |
| TAT/Releasing of Results | : | - |
| Reference Interval/Result Interpretation | : | - |
| Limitations/Interferences | : | Not Applicable |
| Frequently Asked Questions (FAQs) | : | - |
| Related Words/Test | : | Not Applicable |
| Test | : | KIF6 Genotype |
| Other Test Request Name | : | Not applicable |
| Test Composition | : | Not applicable |
| Intended Use | : | This test detects a gene variant associated with increased coronary heart disease (CHD) risk and such CHD event can be reduced from atorvastatin and pravastatin therapy. |
| Methodology | : | Real-Time Polymerase Chain Reaction (RT-PCR) |
| Laboratory Section | : | Special Test |
| Special Instructions/Patient Preparations | : | No patient preparation necessary. |
| Collection/Sample Container | : | EDTA or Violet Tube |
| Specimen and Volume Requirement Note:Follow tube manufacturer recommendation. | : | 2 pcs of 4 mL EDTA whole blood |
| Alternative Specimen and Volume Requirement | : | Not Applicable |
| Specimen Stability | ||
| • Room Temperature (15-25°C) | : | 8 Days |
| • Refrigerated Temperature (2-8°C) | : | 8 Days |
| • Freezer Temperature (-20°C) | : | 30 Days |
| Transport Temperature | : | Transport specimen at 2 – 8 °C (with cold packs) |
| Rejection Criteria | : | • Hemolyzed specimen |
| Running Day | : | Batch Running |
| Cut Off Time | : | Monday, 12:00 PM
|
| TAT/Releasing of Results | : | 2 weeks after cut-off (excluding Saturdays, Sundays and Holidays) |
| Reference Interval/Result Interpretation | : | Not Applicable |
| Limitations/Interferences | : | None specified. |
| Frequently Asked Questions (FAQs) | : | Not applicable |
| Related Words/Test | : | Coronary Heart Disease (CHD) |
| Test | : | KOH |
| Other Test Request Name | : | • KOH prep |
| Test Composition | : | Not applicable |
| Intended Use | : | • It is used for detecting fungal elements. |
| Methodology | : | Direct Microscopic Examination |
| Laboratory Section | : | Bacteriology |
| Special Instructions/Patient Preparations | : | Instructions to Send-in Clients: |
| Collection/Sample Container | : | Clean dry sterile container, plain tube or any tightly closed container |
| Specimen and Volume Requirement Note:Follow tube manufacturer recommendation. | : | With visible materials of the following:
Fluids: 1-3 mL |
| Alternative Specimen and Volume Requirement | : | Not applicable |
| Specimen Stability | ||
| • Room Temperature (15-25°C) | : | 24 Hours |
| • Refrigerated Temperature (2-8°C) | : | Not applicable |
| • Freezer Temperature (-20°C) | : | Not applicable |
| Transport Temperature | : | Transport specimen immediately at room temperature (15°C -25°C). |
| Rejection Criteria | : | • Dried up prepared slides |
| Running Day | : | Daily |
| Cut Off Time | : | Monday to Saturday |
| TAT/Releasing of Results | : | 4 hours after receipt of sample in the laboratory |
| Reference Interval/Result Interpretation | : | NEGATIVE RESULT:
POSITIVE RESULT:
|
| Limitations/Interferences | : |
|
| Frequently Asked Questions (FAQs) | : | Q: What are the causes of positive KOH result but negative in Fungal Culture? A: Inoculated fungi are nonviable; Fungi may have dried during sample processing; Inoculated sample was not enough to include causative fungi; sample chosen/collected from non-optimal site. |
| Related Words/Test | : | Fungal test |
| Test | : | KRAS Mutation |
| Other Test Request Name | : | Not applicable |
| Test Composition | : | Not applicable |
| Intended Use | : | Activating Ras mutations can be found in human malignancies with overall frequency of 15-20%. A high incidence of Ras gene mutations has been reported in 80-90% malignant tumors of the pancreas, 30-60% in colon rectal carcinomas, and in 18-30% of hematopoietic neoplasia of myeloid origin. Ras proteins were shown to influence proliferation, differentiation, transformation, and apoptosis by relaying mitogenic and growth signals into the cytoplasma and the nucleolus. Mutations leading to an amino acid substitution at positions 12,13 and 61 are the most common in naturally occurring neoplasms and are frequent in adenocarcinomas of the pancreas, colon, and certain types of hematological malignancies. |
| Methodology | : | Polymerase Chain Reaction (PCR) |
| Laboratory Section | : | Special Test |
| Special Instructions/Patient Preparations | : | No patient preparation necessary. |
| Collection/Sample Container | : | Slide holders or mailers for microscope slides; FFPE tissue blocks can either be wrapped in paper or placed in a box. |
| Specimen and Volume Requirement Note:Follow tube manufacturer recommendation. | : | • Formalin-fixed paraffin-embedded (FFPE) tissue block |
| Alternative Specimen and Volume Requirement | : | Not Applicable |
| Specimen Stability | ||
| • Room Temperature (15-25°C) | : | Indefinite |
| • Refrigerated Temperature (2-8°C) | : | Not applicable |
| • Freezer Temperature (-20°C) | : | Not applicable |
| Transport Temperature | : | • Microscope slides should be placed in slide holders or mailers and should be adequately padded before placing in a shipping/packaging container to prevent breakage. |
| Rejection Criteria | : | • Incomplete information in the Request Form |
| Running Day | : | Batch Running |
| Cut Off Time | : | Monday to Friday, 12:00 PM
|
| TAT/Releasing of Results | : | 14 days (excluding Saturdays, Sundays and Holidays) |
| Reference Interval/Result Interpretation | : | Not Applicable |
| Limitations/Interferences | : | None specified. |
| Frequently Asked Questions (FAQs) | : | Not applicable |
| Related Words/Test | : | Oncogenes, Normal cells to cancerous cells |
| Test | : | Lactic Acid |
| Other Test Request Name | : | Lactate |
| Test Composition | : | Not applicable |
| Intended Use | : | An intermediate in the glycolytic pathway. Measuring its level can be helpful in evaluating lactic acidosis observed during intense muscular activity, shock and a variety of different conditions including diabetic ketoacidosis, renal or hepatic insufficiency, drug overdosage and certain genetic diseases. |
| Methodology | : | Spectrophotometry |
| Laboratory Section | : | Special Test |
| Special Instructions/Patient Preparations | : |
Note the following info:
|
| Collection/Sample Container | : | Gray Tube |
| Specimen and Volume Requirement Note:Follow tube manufacturer recommendation. | : | 3 mL Plasma |
| Alternative Specimen and Volume Requirement | : | Not Applicable |
| Specimen Stability | ||
| • Room Temperature (15-25°C) | : | Not Applicable |
| • Refrigerated Temperature (2-8°C) | : | 7 Days |
| • Freezer Temperature (-20°C) | : | Not applicable |
| Transport Temperature | : | Transport specimen at 2 – 8 °C (with cold packs) |
| Rejection Criteria | : |
|
| Running Day | : | Monday to Friday |
| Cut Off Time | : | Monday to Friday, 7:00 AM |
| TAT/Releasing of Results | : | After 3 days after cut-off (excluding Saturdays, Sundays and Holidays) |
| Reference Interval/Result Interpretation | : | Available upon request |
| Limitations/Interferences | : | None specified. |
| Frequently Asked Questions (FAQs) | : | Not applicable |
| Related Words/Test | : | Lactic Acid, L-Lactate, CSF Lactate, Lactate |
| Test | : | Lamotrigine |
| Other Test Request Name | : | Lamictal |
| Test Composition | : | Not applicable |
| Intended Use | : | An antiepileptic drug which can induce allergic reactions, especially when taken at the same time as sodium valproate. |
| Methodology | : | LCMS/MS |
| Laboratory Section | : | Special Test |
| Special Instructions/Patient Preparations | : | • No patient preparation necessary.
NOTE: The therapeutic drug monitoring code suggests that the sample should be carried out at the residual rate (just before taking medication). |
| Collection/Sample Container | : | Red tube (DO NOT USE GOLD TUBE or any other type of tube with gel separator) |
| Specimen and Volume Requirement Note:Follow tube manufacturer recommendation. | : | 3 mL Serum |
| Alternative Specimen and Volume Requirement | : | Not Applicable |
| Specimen Stability | ||
| • Room Temperature (15-25°C) | : | 3 Days |
| • Refrigerated Temperature (2-8°C) | : | 7 Days |
| • Freezer Temperature (-20°C) | : | 28 Days |
| Transport Temperature | : | Transport specimen at 2 – 8 °C (with cold packs) |
| Rejection Criteria | : | • Hemolyzed specimen |
| Running Day | : | Batch Running |
| Cut Off Time | : | Friday 4:00 PM |
| TAT/Releasing of Results | : | 3 weeks after cut-off (excluding Saturdays, Sundays and Holidays) |
| Reference Interval/Result Interpretation | : | Available upon request |
| Limitations/Interferences | : | None specified. |
| Frequently Asked Questions (FAQs) | : | Not applicable |
| Related Words/Test | : | Anti-epileptic medication |
| Test | : | LAP - Temporarily Unavailable (currently not accepting samples) |
| Other Test Request Name | : | Leukocyte alkaline phosphatase |
| Test Composition | : | Not applicable |
| Intended Use | : | Aid in the differential diagnosis of chronic myelogenous leukemia (CML) versus leukemoid reaction Aid in the evaluation of polycythemia and myelofibrosis |
| Methodology | : | HPLC/UV Detection |
| Laboratory Section | : | Special Test |
| Special Instructions/Patient Preparations | : | Note the following requirements:
|
| Collection/Sample Container | : | Slide holders or mailers for microscope slides |
| Specimen and Volume Requirement Note:Follow tube manufacturer recommendation. | : | 10 pcs of Peripheral Blood Smear (Wedge-type) -UNSTAINED |
| Alternative Specimen and Volume Requirement | : | Not Applicable |
| Specimen Stability | ||
| • Room Temperature (15-25°C) | : | 7 Days |
| • Refrigerated Temperature (2-8°C) | : | Not applicable |
| • Freezer Temperature (-20°C) | : | Not applicable |
| Transport Temperature | : | Transport specimen at 2 – 8 °C (with cold packs) |
| Rejection Criteria | : |
|
| Running Day | : | Batch Running |
| Cut Off Time | : | Monday to Friday, 7:00 AM |
| TAT/Releasing of Results | : | 1 Month after cut-off (excluding Saturdays, Sundays and Holidays) |
| Reference Interval/Result Interpretation | : | Not Applicable |
| Limitations/Interferences | : | None specified. |
| Frequently Asked Questions (FAQs) | : | Not applicable |
| Related Words/Test | : | Chronic myeloid leukemia |